Table 4.
Cardiac arrhythmia and cardiomyopathy: genetic loci with genome-wide significant association.
| Phenotype | Chromosome | Candidate gene | SNP | P-value | Reference |
|---|---|---|---|---|---|
| Ventricular arrhythmia | |||||
| Sudden cardiac death | 2q24 | TANC1* | rs4665058 | 2×10−10 | [113] |
| Ventricular fibrillation | 21q21 | CXADR | rs2824292 | 3×10−10 | [85] |
| Atrial arrhythmia | |||||
| Atrial fibrillation | 1q21 | KCNN3 | rs13376333 | 2×10−21 | [109] |
| Atrial fibrillation | 1q24 | PRRX1 | rs3903230 | 8×10−14 | [110] |
| Atrial fibrillation | 3p25 | CAND2 | rs4642101 | 1×10−8 | [111] |
| Atrial fibrillation | 4q25 | PITX2 | rs2200733 | 2×10−30 | [106] |
| Atrial fibrillation | 6q22 | GJA1 | rs13216675 | 2×10−8 | [111] |
| Atrial fibrillation | 7q31 | CAV1 | rs3807989 | 4×10−12 | [110] |
| Atrial fibrillation | 9q22 | C9orf3 | rs10821415 | 4×10−11 | [110] |
| Atrial fibrillation | 10q22 | SYNPO2L | rs10824026 | 4×10−9 | [110] |
| Atrial fibrillation | 10q24 | NEURL | rs12415501 | 7×10−16 | [111] |
| Atrial fibrillation | 12q24 | TBX5 | rs10507248 | 6×10−11 | [111] |
| Atrial fibrillation | 12q24 | CUX2 | rs6490029 | 4×10−9 | [111] |
| Atrial fibrillation | 14q23 | SYNE2 | rs1152591 | 6×10−13 | [110] |
| Atrial fibrillation | 15q24 | HCN4 | rs7164883 | 3×10−17 | [110] |
| Atrial fibrillation | 16q22 | ZFHX3 | rs2106261 | 2×10−15 | [107, 108] |
| Sick sinus syndrome | 14q11 | MYH6 | rs2231801 | 1×10−13 | [122] |
| Cardiomyopathy | |||||
| Dilated cardiomyopathy | 1p36 | HSPB7* | rs1739843 | 5×10−13 | [100, 101] |
| Dilated cardiomyopathy | 6p21 | HCG22 | rs9262636 | 5×10−9 | [102] |
| Dilated cardiomyopathy | 10q26 | BAG3* | rs2234962 | 6×10−13 | [100] |
| Hypertrophic cardiomyopathy | 18q12 | FHOD3* | rs2303510 | 2×10−9 | [103] |
| Peripartum cardiomyopathy | 12p11 | PTHLH | rs258415 | 2×10−8 | [99] |
P-values and references refer to the initial discovery study.
coding variant with r2 > 0.9 to index SNP in 1000 Genomes CEU.